de Lemos JA - Search Results

1

Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality.

Gupta S, Rohatgi A, Ayers CR, Willis BL, Haskell WL, Khera A, Drazner MH, de Lemos JA, Berry JD. Gupta S, et al. Among authors: de lemos ja. Circulation. 2011 Apr 5;123(13):1377-83. doi: 10.1161/CIRCULATIONAHA.110.003236. Epub 2011 Mar 21. Circulation. 2011. PMID: 21422392 Free PMC article.

2

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.

de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. de Lemos JA, et al. Circulation. 2003 Feb 11;107(5):690-5. doi: 10.1161/01.cir.0000049742.68848.99. Circulation. 2003. PMID: 12578870 Clinical Trial.

3

B-type natriuretic peptide in cardiovascular disease.

de Lemos JA, McGuire DK, Drazner MH. de Lemos JA, et al. Lancet. 2003 Jul 26;362(9380):316-22. doi: 10.1016/S0140-6736(03)13976-1. Lancet. 2003. PMID: 12892964

4

Nesiritide in acute heart failure.

Drazner M, McGuire DK, de Lemos JA. Drazner M, et al. Among authors: de lemos ja. Lancet. 2003 Sep 20;362(9388):998-9. doi: 10.1016/S0140-6736(03)14380-2. Lancet. 2003. PMID: 14511940 No abstract available.

5

Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.

Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, de Lemos JA. Deo R, et al. Among authors: de lemos ja. J Am Coll Cardiol. 2004 Nov 2;44(9):1812-8. doi: 10.1016/j.jacc.2004.07.047. J Am Coll Cardiol. 2004. PMID: 15519012 Free article.

6

Unexpected BNP levels in patients with advanced heart failure: a tale of caution and promise.

Drazner MH, de Lemos JA. Drazner MH, et al. Among authors: de lemos ja. Am Heart J. 2005 Feb;149(2):187-9. doi: 10.1016/j.ahj.2004.06.009. Am Heart J. 2005. PMID: 15846253 No abstract available.

7

Race and gender differences in C-reactive protein levels.

Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH Jr, Grundy SM, de Lemos JA. Khera A, et al. Among authors: de lemos ja. J Am Coll Cardiol. 2005 Aug 2;46(3):464-9. doi: 10.1016/j.jacc.2005.04.051. J Am Coll Cardiol. 2005. PMID: 16053959 Free article.

8

Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study.

de Lemos JA, Zirlik A, Schönbeck U, Varo N, Murphy SA, Khera A, McGuire DK, Stanek G, Lo HS, Nuzzo R, Morrow DA, Peshock R, Libby P. de Lemos JA, et al. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2192-6. doi: 10.1161/01.ATV.0000182904.08513.60. Epub 2005 Aug 18. Arterioscler Thromb Vasc Biol. 2005. PMID: 16109925

9

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.

Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA. Das SR, et al. Among authors: de lemos ja. Circulation. 2005 Oct 4;112(14):2163-8. doi: 10.1161/CIRCULATIONAHA.105.555573. Circulation. 2005. PMID: 16203929

10

Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study).

Abdullah SM, Khera A, Das SR, Stanek HG, Canham RM, Chung AK, Morrow DA, Drazner MH, McGuire DK, de Lemos JA. Abdullah SM, et al. Among authors: de lemos ja. Am J Cardiol. 2005 Nov 1;96(9):1284-9. doi: 10.1016/j.amjcard.2005.06.073. Epub 2005 Sep 9. Am J Cardiol. 2005. PMID: 16253599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters